STOCK TITAN

Kamada (KMDA) to join September investor conferences in new report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Kamada Ltd. submitted a report as a foreign private issuer stating that it files its annual reports on Form 20-F. The report is being incorporated by reference into several existing Form S-8 registration statements. It also attaches an exhibit announcing Kamada’s participation in upcoming September investor conferences.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the Month of September 2025

 

Commission File Number 001-35948

 

Kamada Ltd.

(Translation of registrant’s name into English)

 

2 Holzman Street
Science Park, P.O. Box 4081
Rehovot 7670402
Israel
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F       Form 40-F

 

 

 

 

 

This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements, File Nos. 333-192720, 333-207933, 333-215983, 333-222891, 333-233267 and 333-265866.

 

1

 

 

The following exhibit is attached:

 

99.1   Kamada to Participate in Upcoming September Investor Conferences

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 2, 2025 KAMADA LTD.
     
  By: /s/ Nir Livneh
    Nir Livneh
Vice President General Counsel and Corporate Secretary

 

3

 

 

EXHIBIT INDEX

 

EXHIBIT NO.   DESCRIPTION
99.1   Kamada to Participate in Upcoming September Investor Conferences

 

4

 

FAQ

What does Kamada Ltd. (KMDA) report in this September 2025 document?

Kamada Ltd. reports as a foreign private issuer and notes that this report is incorporated by reference into several existing Form S-8 registration statements, while also attaching an exhibit about participation in upcoming September investor conferences.

Which annual report form does Kamada Ltd. (KMDA) use?

Kamada Ltd. states that it files its annual reports on Form 20-F. This confirms it follows the U.S. reporting framework typically used by foreign private issuers rather than the Form 40-F framework for certain Canadian filers.

How is this Kamada Ltd. (KMDA) report linked to its Form S-8 registrations?

The report is expressly incorporated by reference into Kamada’s Form S-8 registration statements with file numbers 333-192720, 333-207933, 333-215983, 333-222891, 333-233267 and 333-265866, extending those employee benefit plan registrations with this new information.

What exhibit is included with this Kamada Ltd. (KMDA) filing?

The filing includes Exhibit 99.1 titled “Kamada to Participate in Upcoming September Investor Conferences.” This indicates the attached material provides more detail about the company’s participation in investor conferences during September.

Where is Kamada Ltd. (KMDA) headquartered according to this report?

Kamada Ltd. lists its principal executive offices at 2 Holzman Street, Science Park, P.O. Box 4081, Rehovot 7670402, Israel. This confirms the company’s headquarters location as disclosed in the report’s cover information.
Kamada Ltd

NASDAQ:KMDA

View KMDA Stock Overview

KMDA Rankings

KMDA Latest News

KMDA Latest SEC Filings

KMDA Stock Data

481.10M
31.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Rehovot